Matteo Landriscina

Has grant

Professor of Medical Oncology

Università degli Studi di Foggia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matteo Landriscina is a Professor of Medical Oncology at Università degli Studi di Foggia, Italy. His research interests encompass various aspects of oncology, including the molecular landscape of colorectal tumors, CDK4/6 inhibitor therapy in elderly patients, and treatment strategies for recurrent glioblastoma. He has published extensively on the implications of molecular subtyping in bladder cancer and the role of PD-L1 expression in prostate cancer.

Recent Grants

Grant: Close

Cancer type-specific regulation of cell metabolism by TRAP1: impact on malignant phenotypes and drug resistance/design

Open Date: 2016-01-01

Close Date: 2018-01-01

Grant: Close

Role of TRAP1 in the molecular and clinical features of human BRAF-driven colorectal and thyroid carcinomas: a novel molecular target

Open Date: 2014-01-01

Close Date: 2016-01-01

Grant: Close

TRAP1 controls stress-adaptive responses of cancer cells: a novel molecular target in drug resistance

Open Date: 2013-01-01

Close Date: 2015-01-01

Grant: Close

The role of TRAP1 in the resistance to anti-EGFR1 agents in human colorectal carcinoma

Open Date: 2012-01-01

Close Date: 2015-01-01

Grant: Close

Role of TRAP1, a novel antiapoptotic gene, in the resistance to anticancer therapy in colon and breast tumors

Open Date: 2010-01-01

Close Date: 2012-01-01

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Elena De Santis

Sapienza University of Rome

ITALY

View details

Alessandro Tafuni

University of Parma

ITALY

View details

Jatin Gandhi

Emory University

UNITED STATES

View details

Dario de Biase

Associate Professor

University of Bologna

ITALY

View details

Vincenza Conteduca

Associate Professor

University of Foggia

ITALY

View details

Cristina Magi‐Galluzzi

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matteo Landriscina

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

The Molecular Landscape of Colorectal Laterally Spreading Tumors: From Endoscopic Subtypes to Molecular Targets

Androgen receptor, PARP signaling, and tumor microenvironment: the ‘perfect triad’ in prostate cancer?

Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study

Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations

Collaborators (6)

Elena De Santis

Alessandro Tafuni

Jatin Gandhi

Dario de Biase

Vincenza Conteduca

Cristina Magi‐Galluzzi

Make your next move.